Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CCKBR | P32239 | 9/20 | 0.57 |
| ▸ | CCKAR | P32238 | 6/20 | 0.57 |
| ▸ | LMNA | P02545 | 1/20 | 0.43 |
| ▸ | POLB | P06746 | 1/20 | 0.43 |
| ▸ | MAPT | P10636 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8803196 | 0.92 | CCKBR (0.47) | CCKBRCCKAR | |
| SCHEMBL8667990 | 0.90 | CCKBR (0.55) | CCKBRCCKARLMNA | |
| SCHEMBL8800940 | 0.89 | CCKBR (0.64) | CCKBRCCKARLMNAPOLBMAPT | |
| SCHEMBL8804138 | 0.83 | CCKBR (0.42) | CCKBRCCKAR | |
| SCHEMBL8669226 | 0.81 | CCKBR (0.50) | CCKBRCCKARLMNAPOLBMAPT | |
| SCHEMBL8669189 | 0.81 | CCKBR (0.58) | CCKBRCCKAR | |
| SCHEMBL8801216 | 0.76 | CCKBR (0.39) | CCKBRCCKARMAPT | |
| SCHEMBL8801767 | 0.76 | BRD4 (0.41) | CCKBRLMNAMAPT | |
| SCHEMBL8800433 | 0.74 | CCKBR (0.46) | CCKBRCCKAR | |
| SCHEMBL7544921 | 0.73 | CCKBR (0.54) | CCKBRCCKAR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-5843941-A | Ras farnesyl transferase inhibitors | GENENTECH, INC. (US) | 1998-12-01 | — | — | US | disclosed |
| EP-0763537-A2 | Non-peptidyl Ras farnesyl transferase inhibitors | GENENTECH, INC. (US) | 1997-03-19 | — | — | EP | disclosed |
| WO-1994026723-A2 | ras FARNESYL TRANSFERASE INHIBITORS | GENENTECH, INC. (US) | 1994-11-24 | — | — | WO | disclosed |